Chemiluminescence immunoassay analyzer: precise detection, assisting in health defense line

With the continuous development of medical technology, chemiluminescence immunoassay analyzer, as an advanced detection device, has played an increasingly important role in the field of clinical medicine. It achieves precise detection of multiple biomarkers through chemiluminescence technology, providing strong support for early diagnosis, efficacy monitoring, and prognosis evaluation of diseases. This article will introduce the items that can be detected by chemiluminescence immunoassay analyzer and its application in clinical practice.

1、 Detection items of chemiluminescence immunoassay analyzer

1. * * Tumor biomarker detection * *: such as alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), prostate-specific antigen (PSA), etc., used for early screening, diagnosis, and efficacy monitoring of tumors.

2. * * Autoantibody testing * *: such as anti nuclear antibodies (ANA), anti double stranded DNA antibodies (dsDNA), anti Smith antibodies (Sm), etc., used for the diagnosis of autoimmune diseases.

3. * * Hormone testing * *: such as thyroid function testing (TSH, FT4, FT3), sex hormone testing (FSH, LH, E2, P), adrenal cortex hormone testing, etc., used for the diagnosis and monitoring of endocrine diseases.

4. * * Detection of infectious disease markers * *: such as hepatitis B virus (HBV) markers, hepatitis C virus (HCV) markers, human immunodeficiency virus (HIV) markers, etc., used for the diagnosis and monitoring of infectious diseases.

5. * * Inflammatory biomarker detection * *: such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), etc., used for the diagnosis and monitoring of inflammatory diseases.

6. * * Drug concentration detection * *: such as antibiotics, antiepileptic drugs, immunosuppressants, etc., used for drug concentration monitoring and personalized medication guidance.

7. * * Bone metabolism marker detection * *: such as bone alkaline phosphatase (ALP), serum calcium, serum phosphorus, etc., used for the diagnosis and monitoring of osteoporosis and bone metabolism diseases.

8. * * Cardiovascular marker detection * *: such as cardiac troponin I (cTnI), creatine kinase isoenzyme (CK-MB), etc., used for the diagnosis and monitoring of cardiovascular diseases.

2、 Application of chemiluminescence immunoassay analyzer in clinical practice

1. * * Early screening * *: By detecting tumor markers, autoantibodies, etc., early screening of diseases can be achieved to improve the cure rate.

2. Diagnosis: Based on the test results, provide clinical doctors with diagnostic basis and improve diagnostic accuracy.

3. * * Efficacy monitoring * *: During the treatment process, relevant biomarkers are detected to evaluate the treatment effect and adjust the treatment plan.

4. * * Prognostic evaluation * *: Based on the test results, evaluate the prognosis of the disease and provide decision-making basis for clinical doctors.

5. * * Individualized medication * *: Based on the results of drug concentration testing, individualized medication can be used to improve treatment efficacy and reduce drug side effects.